Inspire Medical Systems (NYSE:INSP - Get Free Report) announced its earnings results on Monday. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.41, Zacks reports. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%.
Inspire Medical Systems Trading Up 0.1 %
INSP traded up $0.22 during mid-day trading on Thursday, hitting $187.23. 622,337 shares of the stock were exchanged, compared to its average volume of 624,818. The firm's fifty day moving average is $189.20 and its two-hundred day moving average is $191.36. Inspire Medical Systems has a 1-year low of $123.00 and a 1-year high of $257.40. The company has a market cap of $5.61 billion, a PE ratio of 174.98 and a beta of 1.32.
Analyst Ratings Changes
INSP has been the topic of several recent research reports. Royal Bank of Canada restated an "outperform" rating and set a $260.00 target price on shares of Inspire Medical Systems in a report on Tuesday. KeyCorp restated an "overweight" rating and issued a $234.00 target price (down from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Piper Sandler lowered their price target on shares of Inspire Medical Systems from $260.00 to $233.00 and set an "overweight" rating on the stock in a research report on Monday. Truist Financial cut their price objective on shares of Inspire Medical Systems from $250.00 to $235.00 and set a "buy" rating for the company in a research report on Tuesday. Finally, Robert W. Baird reduced their target price on shares of Inspire Medical Systems from $252.00 to $248.00 and set an "outperform" rating on the stock in a research note on Tuesday. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $228.82.
View Our Latest Stock Report on INSP
About Inspire Medical Systems
(
Get Free Report)
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.
See Also
Before you consider Inspire Medical Systems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Inspire Medical Systems wasn't on the list.
While Inspire Medical Systems currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
